Alan Whone

4.9k citations
68 papers · 2.9k · 2 hit papers · h-index 26

Impact in

  • Neurology top 0.5%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Botulinum Toxin and Related Neurological Disorders
    • Genetic Neurodegenerative Diseases
    • Nuclear Receptors and Signaling
    • Neuroscience and Neuropharmacology Research

Papers in

    • Parkinson's Disease Mechanisms and Treatments 35
    • Neurological disorders and treatments 28
    • Transcranial Magnetic Stimulation Studies 3
    • Botulinum Toxin and Related Neurological Disorders 3
    • Genetic Neurodegenerative Diseases 6
    • Nerve injury and regeneration 4

Alan Whone

64 papers receiving 2.8k citations

Alan Whone's Hit Papers

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial 2016 · 207 citations
2070+7+15Years since publication200400600

Peers

Alan Whone
Comparison fields: 5 of 113
  • Neurology 1.8k
  • Cellular and Molecular Neuroscience 843
  • Physical Therapy, Sports Therapy and Rehabilitation 157
  • Neurology 233
  • Cognitive Neuroscience 273
Replace Sharon Hassin‐Baer with:
Sharon Hassin‐Baer Israel
Marina Svetel Serbia
Kathryn A. Chung United States
Daniel G. Healy United Kingdom
Tommaso Schirinzi Italy
Ioannis U. Isaias Italy
Pramod Kumar Pal India
Stella M. Papa United States
Chun‐Hwei Tai Taiwan
Qianqian Wei China
Alan Whone relative to Sharon Hassin‐Baer Israel Sharon Hassin‐Baer's profile →
Citations per field
00.5×1.5×2.2×
Sharon Hassin‐Baer · 1×
Citations per year

Countries citing papers authored by Alan Whone

Since Specialization
Citations

This map shows the geographic impact of Alan Whone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Whone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Whone more than expected).

Fields of papers citing papers by Alan Whone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Whone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Whone. The network helps show where Alan Whone may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Whone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Whone Line = papers co-authored together Alan Whone links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Hit paper breakdown →
2003607
2 2015260
3
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial
Hit paper breakdown →
2016207
4 2014158
5 2002132
6 2015123
7 2007109
8 2011105
9 201175
10 200371
11 201264
12 200459
13 201058
14 202058
15 201157
16 201253
17 201143
18 202040
19 201639
20
201737

About Alan Whone

Alan Whone is a scholar working on Neurology, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Physical Therapy, Sports Therapy and Rehabilitation and Psychiatry and Mental health, having authored 68 papers that have together received 2.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (28 papers), Balance, Gait, and Falls Prevention (7 papers), Genetic Neurodegenerative Diseases (6 papers), Nerve injury and regeneration (4 papers), Transcranial Magnetic Stimulation Studies (3 papers), Dementia and Cognitive Impairment Research (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). The work is most often cited by research in Neurology (1.8k citations), Cellular and Molecular Neuroscience (843 citations), Physical Therapy, Sports Therapy and Rehabilitation (157 citations), Neurology (233 citations) and Cognitive Neuroscience (273 citations). Alan Whone has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David J. Brooks, Robert Y. Moore, Paola Piccini, Philippe Rémy, Werner Poewe, Sven N. Reske, A. Jon Stoessl, Anthony E. Lang, Olivier Rascol and Ray L. Watts. Their work appears in journals such as Neurosurgery, Neuropsychologia, The Lancet Neurology, Journal of Parkinson s Disease and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact